UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058643
Receipt number R000067052
Scientific Title Effects on physical function by wearing a band that generates far-infrared rays and weak electric currents around the ankle: open study
Date of disclosure of the study information 2025/07/30
Last modified on 2025/07/30 10:28:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects on physical function by wearing a band that generates far-infrared rays and weak electric currents around the ankle

Acronym

R-engine study

Scientific Title

Effects on physical function by wearing a band that generates far-infrared rays and weak electric currents around the ankle: open study

Scientific Title:Acronym

Effects on physical function by wearing a band that generates far-infrared rays and weak electric currents around the ankle

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluating the effects on physical function by wearing the test product

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Objective evaluation

Key secondary outcomes

subjective evaluation


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Wearing test article

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

25 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy men and women

Key exclusion criteria

aaa1.Subjects with a history of treatment that affects the test site
2.Subjects who have started taking a new medication within the last 2 months
3.Subjects who attend chiropractic clinics, sports gyms, or yoga classes
4. Subjects who have participated in other clinical trials within one month prior to obtaining consent, or subjects who plan to participate in other clinical trials
5. Subjects who are pregnant or breastfeeding, or those who plan to do so (including subjects who have just given birth)
6. Subjects with alcoholism or heavy smokers
7. Subjects with a history of food allergies
8. Subjects receiving hormone replacement therapy
9. Subjects who cannot walk independently without assistance
10. Subjects suspected of mild or severe dementia
11. Others who the principal investigator deems inappropriate

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Kaneko

Organization

Japan Clinical Trial Association

Division name

N.A.

Zip code

1600022

Address

5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo

TEL

0364574666

Email

info@yakujihou.org


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Kaneko

Organization

Japan Clinical Trial Association

Division name

N.A.

Zip code

1600022

Address

5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo

TEL

0364574666

Homepage URL


Email

info@yakujihou.org


Sponsor or person

Institute

Japan Clinical Trial Association

Institute

Department

Personal name



Funding Source

Organization

Relive Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Pharmaceutical Law Wisdoms

Address

5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo

Tel

0364574911

Email

master@yakujihou.net


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 07 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 06 Month 18 Day

Date of IRB

2025 Year 07 Month 10 Day

Anticipated trial start date

2025 Year 07 Month 30 Day

Last follow-up date

2025 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 07 Month 30 Day

Last modified on

2025 Year 07 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067052